Hematopoietic cell transplantation for tolerance induction

  • Norma S. Kenyon
  • Camillo Ricordi


A major focus of the entire transplant community has been to delineate anti-rejection strategies which, alone or via multifaceted approaches, result in the development of donor specific tolerance, thus obviating the need for chronic, generalized immunosuppression of the recipient. Many approaches which have proven successful in rodent models of solid organ or cellular transplantation have not translated well to large animals or humans. This may be due, in part, to a need for multifaceted immunointerventions when transplanting cells or organs between members of outbred, large animal populations.


Graft Versus Host Disease Hematopoietic Cell Transplantation Allograft Survival Donor Bone Marrow Renal Allograft Survival 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Charlton B, Aunchicloss Jr H, Fathman CG (1994) Mechanisms of transplantation tolerance. Annu Rev Immunol: 707–734.Google Scholar
  2. 2.
    Waldmann TA (1992) Immune receptors: Targets for therapy of leukemia/lymphoma, autoimmune diseases and for the prevention of allograft rejection. Annu Rev Immunol 10: 675–704.PubMedCrossRefGoogle Scholar
  3. 3.
    Kenyon NS, Strasser S and Alejandro R (1990) Ultraviolet light immunomodulation of canine islets for prolongation of allograft survival. Diabetes 39 (3): 305–311.PubMedCrossRefGoogle Scholar
  4. 4.
    Alejandro R, Latif Z, Noel J et al. (1987) Effect of anti-Ia antibodies, culture and cyclosporin on prolongation of canine islet allograft survival. Diabetes 36 (3): 269–273.PubMedCrossRefGoogle Scholar
  5. 5.
    Billingham RE, Brent L and Medawar PB (1953) Actively acquired tolerance of foreign cells. Nature 172: 603–606.PubMedCrossRefGoogle Scholar
  6. 6.
    Billingham RE and Brent L (1954) Quantitative studies of tissue transplantation immunity. II. The origins, strength and duration of actively and adoptively acquired immunity. Proc R Soc B 143: 58–80.CrossRefGoogle Scholar
  7. 7.
    Lee S and Fisher B (1961) Portocaval shunt in the rat. Surgery 50: 668–673.PubMedGoogle Scholar
  8. 8.
    Fabre JW, Lim SH and Moms PJ (1971) Renal transplantation in the rat: Details of a technique. Aust NZ J Surgery 41: 69–75.Google Scholar
  9. 9.
    Stuart FP, Saitoh T and Fitch FW (1968) Rejection of renal allografts: Specific immunologic suppression. Science 160: 1463–1465.CrossRefGoogle Scholar
  10. 10.
    French ME and Batchelor JR (1969) Immunological enhancement of rat kidney grafts. Lancet 2: 1103–1106.PubMedCrossRefGoogle Scholar
  11. 11.
    Opelz G, Sengar DPS, Mickey MR et al. (1973) Effect of blood transfusions on subsequent kidney transplants. Transplant Proc 5: 253–259.PubMedGoogle Scholar
  12. 12.
    De Waal LP and Van Twuyver E (1991) Blood transfusions and allograft survival: Is mixed chimerism the solution for tolerance induction in clinical transplantation? Crit Rev Immunol 10: 417–425.PubMedGoogle Scholar
  13. 13.
    Thomas JM, Carver FM, Cunningham PR et al. (1991) Kidney allograft tolerance in primates without chronic immunosuppression–the role of veto cells. Transplantation 51: 198–207.PubMedCrossRefGoogle Scholar
  14. 14.
    Thomas JM, Carver FM, Kasten-Jolly J et al. (1994) Further studies of veto activity in rhesus monkey bone marrow in relation to allograft tolerance and chimerism. Transplantation 57: 101–115.PubMedCrossRefGoogle Scholar
  15. 15.
    Thomas JM, Verbanac KM and Thomas FT (1991) The veto mechanism in transplant tolerance. Transplantation Rev 5: 209–229.CrossRefGoogle Scholar
  16. 16.
    Kaufman CL, Colson YL, Wren SM et al. (1994) Phenotypic characterization of a novel bone marrow-derived cell that facilitates engraftment of allogeneic bone marrow stem cells. Blood 84 (8): 2436–2446.PubMedGoogle Scholar
  17. 17.
    Monaco AP, Wood ML and Russel PS (1966) Studies on heterologous anti-lymphocyte serum in mice: III. Immunologic tolerance and chimerism produced across the H-2 locus with adult thymectomy and anti-lymphocyte serum. Ann NY Acad Sci 129: 190–206.CrossRefGoogle Scholar
  18. 18.
    Harmer WC, De Fazio SR, Maki T et al. (1986) Prolongation of renal allograft survival in antilymphocyte-serumtreated dogs by postoperative injection of density-gradientfractionated donor bone marrow. Transplantation 42 (6): 593–597.CrossRefGoogle Scholar
  19. 19.
    Monaco AP, Clark Aw, Wood ML et al. (1976) Possible active enhancement of a human cadaver renal allograft with antilymphocytic serum (ALS) and donor bone marrow: Case report of an initial attempt. Surgery 79: 384–392.PubMedGoogle Scholar
  20. 20.
    McDaniel DO, Naftilan J, Hulvey K et al. (1994) Peripheral blood chimerism in renal allograft recipients transfused with donor bone marrow. Transplantation 57: 852–856.PubMedCrossRefGoogle Scholar
  21. 21.
    Stewart FM, Crittenden RB, Lowry PA et al. (1993) Long-term engraftment of normal and post-5-fluorouracil murine marrow into normal mice. Blood 81: 2566–2571.PubMedGoogle Scholar
  22. 22.
    Harrison DE (1993) Competitive repopulation in unirradiated normal recipients. Blood 81: 2473–2474.PubMedGoogle Scholar
  23. 23.
    Starzl TE, Demetris AJ, Trucco M et al. (1993) Chimerism and donor specific nonreactivity 27 to 29 years after kidney allotransplantation. Transplantation 55: 1272–1277.PubMedCrossRefGoogle Scholar
  24. 24.
    Starzl TE, Demetris AJ, Murase N et al. (1993) Donor cell chimerism permitted by immunosuppressive drugs: a probable basis of organ transplant acceptance and tolerance. Immunology Today 14: 326–332.PubMedCrossRefGoogle Scholar
  25. 25.
    Ricordi C, Ildstad ST, Demetris AJ et al. (1992) Donor dendritic cells repopulation in recipients after rat-to-mouse bone marrow transplantation. Lancet 339: 1610–1611.PubMedCrossRefGoogle Scholar
  26. 26.
    Ricordi C, Ildstad ST and Starzl Te (1992) Induction of pancreatic islet graft acceptance: The role of antigen presenting cells. Transplantation Science 2: 34–38.PubMedGoogle Scholar
  27. 27.
    Ricordi C, Tzakis AG, Demetris AJ et al. (1993) Reversal of graft-versus-host disease with infusion of stored autologous hone marrow cells following combined liver-bone marrow allotransplantation in man. Transplantation Science 3: 76–77.PubMedGoogle Scholar
  28. 28.
    Ricordi C, Tzakis Ag, Zeevi A et al. (1994) Reversal of graftversus-host disease with infusion of autologous bone marrow. Cell Transplant 3: 187–192.PubMedGoogle Scholar
  29. 29.
    Fontes P, Rao A, Demetris AJ et al. (1994) Augmentation with bone marrow of donor leukocyte migration for kidney, liver, heart, and pancreas islet transplantation. Lancet 344: 151–155.PubMedCrossRefGoogle Scholar
  30. 30.
    Brendel M, Kong SS, Schachner RD et al. (1995) The effect of donor specific vertebral body derived bone marrow cell infusion on islet allograft survival in the dog without cytoablative conditioning of the recipient. Presented at the International Symposium on Tolerance Induction, Breckenridge, Colorado, Jan 22–25.Google Scholar
  31. 31.
    Ricordi C, Karatzas T, Selvaggi G et al. (1995) Multiple bone marrow infusions to enhance acceptance of allografts from the same donor. Ann NY Acad Sci: in press.Google Scholar

Copyright information

© Kluwer Academic Publishers 1996

Authors and Affiliations

  • Norma S. Kenyon
    • 1
  • Camillo Ricordi
    • 1
  1. 1.Diabetes Research InstituteUniversity of Miami School of MedicineMiamiUSA

Personalised recommendations